Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease

Kidney International

Volumn 89, Issue 4, 2016, Pages 874-885

  Bramham, Kate ^a   Seed, Paul T ^a   Lightstone, Liz ^b   Nelson Piercy, Catherine ^a   Gill, Carolyn ^a   Webster, Philip ^b   Poston, Lucilla ^a   Chappell, Lucy C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

chronic kidney disease; endothelium; proteinuria

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACENTAL GROWTH FACTOR; RELAXIN; VASCULOTROPIN RECEPTOR 1; LCN2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UMBILICAL ARTERY; UTERINE ARTERY; ACUTE KIDNEY INJURY; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMPLICATION; GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; VALIDATION STUDY;

ACUTE KIDNEY INJURY; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; LIPOCALIN-2; LONGITUDINAL STUDIES; NATRIURETIC PEPTIDE, BRAIN; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; RELAXIN; RENAL INSUFFICIENCY, CHRONIC;

EID: 84964667597     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2015.10.012     Document Type: Article

References (34)

1. E.A. Steegers, P. von Dadelszen, J.J. Duvekot, and et al. Pre-eclampsia Lancet 376 2010 631 644
2. K. Bramham, B. Parnell, C. Nelson-Piercy, and et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis BMJ 348 2014 g2301
3. D. Williams, and J. Davison Chronic kidney disease in pregnancy BMJ 336 2008 211 215
4. D.C. Crews, L.C. Plantinga, E.R. Miller 3rd, and et al. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States Hypertension 55 2010 1102 1109
5. S.E. Maynard, and S.A. Karumanchi Angiogenic factors and preeclampsia Semin Nephrol 31 2011 33 46
6. R.J. Levine, S.E. Maynard, C. Qian, and et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
7. C.J. Robinson, D.D. Johnson, E.Y. Chang, and et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia Am J Obstet Gynecol 195 2006 255 259
8. S.E. Maynard, J.Y. Min, J. Merchan, and et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
9. J.L. Resnik, C. Hong, R. Resnik, and et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women Am J Obstet Gynecol 193 2005 450 454
10. A. Hamaoui, and R. Mercado Evaluation of B-type natriuretic peptide levels in singleton hypertensive minority women J Reprod Med 57 2012 39 42
11. K. Melchiorre, G. Sutherland, R. Sharma, and et al. Mid-gestational maternal cardiovascular profile in preterm and term pre-eclampsia: a prospective study BJOG 120 2013 496 504
12. H. Stepan, A. Philipp, M. Reiche, and et al. Serum levels of the adipokine lipocalin-2 are increased in preeclampsia Journal of endocrinological investigation 33 2010 629 632
13. R. D'Anna, G. Baviera, D. Giordano, and et al. Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia Acta Obstet Gynecol Scand 89 2010 275 278
14. K.P. Conrad, and J.M. Davison The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol 306 2014 F1121 F1135
15. L.C. Chappell, S. Duckworth, P.T. Seed, and et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study Circulation 128 2013 2121 2131
16. R. Thadhani, W.P. Mutter, M. Wolf, and et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
17. O. Erez, R. Romero, J. Espinoza, and et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 2008 279 287
18. National Institute for Clinical Excellence. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy (clinical guideline 107) 2010. Available at: http://www.nice.org.uk/CG107. Accessed December 21, 2014.
19. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy Obstet Gynecol 122 2013 1122 1131
20. R.J. Levine, R. Thadhani, C. Qian, and et al. Urinary placental growth factor and risk of preeclampsia JAMA 293 2005 77 85
21. H. Masuyama, N. Suwaki, H. Nakatsukasa, and et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis Am J Obstet Gynecol 194 2006 551 556
22. H. Masuyama, E. Nobumoto, N. Okimoto, and et al. Superimposed preeclampsia in women with chronic kidney disease Gynecol Obstet Invest 74 2012 274 281
23. A. Rolfo, R. Attini, A.M. Nuzzo, and et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers Kidney Int 83 2013 177 181
24. S. Sunderji, E. Gaziano, D. Wothe, and et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study Am J Obstet Gynecol 202 2010 40 e41-e47
25. U. Perni, C. Sison, V. Sharma, and et al. Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy Hypertension 59 2012 740 746
26. S. Salahuddin, Y. Lee, M. Vadnais, and et al. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy Am J Obstet Gynecol 197 2007 28 e21-e26
27. B.K. Dwyer, S. Krieg, R. Balise, and et al. Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia J Matern Fetal Neonatal Med 23 2010 705 711
28. Piccoli GB, Gaglioti P, Parisi S, et al. Pre-eclampsia or chronic kidney disease? The flow hypothesis. Nephrol Dial Transplant 28:1199-1206.
29. M.A. Brown, M.D. Lindheimer, M. de Swiet, and et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 IX XIV
30. A.S. Levey, J.P. Bosch, J.B. Lewis, and et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann of Intern Med 130 1999 461 470
31. Clinical practice guideline on acute kidney injury. Brussels: Kidney Disease: Improving Global Outcomes (vol 2014), 2011. Available at: http://www.kdigo.org/clinical-practice-guidelines/pdf. Accessed December 21, 2014.
32. Gardosi J, Francis A. Gestation network. Available at: http://www.gestation.net. Accessed December 21, 2014.
33. C. Saffer, G. Olson, K. Boggess, R. Beyerlein, et al. NORMALS Study Group Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia Pregnancy Hypertens 3 2013 124 132
34. A. Skrondal, and S. Rabe-Hesketh Generalized Latent Variable Modeling: Multilevel, Longitudinal and Structural Equation Models 2004 Chapman & Hall/CRC Press Boca Raton, FL